108 related articles for article (PubMed ID: 18499410)
1. Drug permeability across a phospholipid vesicle-based barrier 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability.
Flaten GE; Luthman K; Vasskog T; Brandl M
Eur J Pharm Sci; 2008 Jul; 34(2-3):173-80. PubMed ID: 18499410
[TBL] [Abstract][Full Text] [Related]
2. Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.
Flaten GE; Skar M; Luthman K; Brandl M
Eur J Pharm Sci; 2007 Mar; 30(3-4):324-32. PubMed ID: 17204409
[TBL] [Abstract][Full Text] [Related]
3. Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes.
Flaten GE; Bunjes H; Luthman K; Brandl M
Eur J Pharm Sci; 2006 Jul; 28(4):336-43. PubMed ID: 16697561
[TBL] [Abstract][Full Text] [Related]
4. In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier.
Kanzer J; Tho I; Flaten GE; Mägerlein M; Hölig P; Fricker G; Brandl M
J Pharm Pharmacol; 2010 Nov; 62(11):1591-8. PubMed ID: 21039543
[TBL] [Abstract][Full Text] [Related]
5. In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants.
Fischer SM; Flaten GE; Hagesæther E; Fricker G; Brandl M
J Pharm Pharmacol; 2011 Aug; 63(8):1022-30. PubMed ID: 21718285
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel human stratum corneum model, as a tool in the optimization of drug formulations.
Shakel Z; Nunes C; Costa Lima SA; Reis S
Int J Pharm; 2019 Oct; 569():118571. PubMed ID: 31352050
[TBL] [Abstract][Full Text] [Related]
7. Application of simulated intestinal fluid on the phospholipid vesicle-based drug permeation assay.
Fischer SM; Buckley ST; Kirchmeyer W; Fricker G; Brandl M
Int J Pharm; 2012 Jan; 422(1-2):52-8. PubMed ID: 22027395
[TBL] [Abstract][Full Text] [Related]
8. [Study of the effect of surface-active agents on living cells, used as component parts in microemulsions, based on their chemical structures and critical micelle-formative concentration (CMC)].
Ujhelyi Z; Vecsernyés M; Bácskay I
Acta Pharm Hung; 2013; 83(1):3-11. PubMed ID: 23821837
[TBL] [Abstract][Full Text] [Related]
9. Permeapad™ for investigation of passive drug permeability: The effect of surfactants, co-solvents and simulated intestinal fluids (FaSSIF and FeSSIF).
Bibi HA; di Cagno M; Holm R; Bauer-Brandl A
Int J Pharm; 2015 Sep; 493(1-2):192-7. PubMed ID: 26192628
[TBL] [Abstract][Full Text] [Related]
10. Optimized conditions of bio-mimetic artificial membrane permeation assay.
Sugano K; Hamada H; Machida M; Ushio H; Saitoh K; Terada K
Int J Pharm; 2001 Oct; 228(1-2):181-8. PubMed ID: 11576780
[TBL] [Abstract][Full Text] [Related]
11. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
[TBL] [Abstract][Full Text] [Related]
12. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.
Flaten GE; Dhanikula AB; Luthman K; Brandl M
Eur J Pharm Sci; 2006 Jan; 27(1):80-90. PubMed ID: 16246536
[TBL] [Abstract][Full Text] [Related]
13. Development of a biomimetic phospholipid vesicle-based permeation assay for the estimation of intestinal drug permeability.
Naderkhani E; Isaksson J; Ryzhakov A; Flaten GE
J Pharm Sci; 2014 Jun; 103(6):1882-90. PubMed ID: 24665049
[TBL] [Abstract][Full Text] [Related]
14. Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: formulation, characterization, cytotoxicity and permeability enhancement study.
Bandivadekar M; Pancholi S; Kaul-Ghanekar R; Choudhari A; Koppikar S
Drug Dev Ind Pharm; 2013 May; 39(5):696-703. PubMed ID: 22616839
[TBL] [Abstract][Full Text] [Related]
15. Understanding of Relationship between Phospholipid Membrane Permeability and Self-Diffusion Coefficients of Some Drugs and Biologically Active Compounds in Model Solvents.
Blokhina SV; Volkova TV; Golubev VA; Perlovich GL
Mol Pharm; 2017 Oct; 14(10):3381-3390. PubMed ID: 28850240
[TBL] [Abstract][Full Text] [Related]
16. Solubilization of cyclosporin A.
Ran Y; Zhao L; Xu Q; Yalkowsky SH
AAPS PharmSciTech; 2001 Jan; 2(1):E2. PubMed ID: 14727890
[TBL] [Abstract][Full Text] [Related]
17. A new PAMPA model proposed on the basis of a synthetic phospholipid membrane.
Yu H; Wang Q; Sun Y; Shen M; Li H; Duan Y
PLoS One; 2015; 10(2):e0116502. PubMed ID: 25647086
[TBL] [Abstract][Full Text] [Related]
18. Biomimetic PVPA in vitro model for estimation of the intestinal drug permeability using fasted and fed state simulated intestinal fluids.
Naderkhani E; Vasskog T; Flaten GE
Eur J Pharm Sci; 2015 Jun; 73():64-71. PubMed ID: 25840125
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer.
Ujhelyi Z; Fenyvesi F; Váradi J; Fehér P; Kiss T; Veszelka S; Deli M; Vecsernyés M; Bácskay I
Eur J Pharm Sci; 2012 Oct; 47(3):564-73. PubMed ID: 22841998
[TBL] [Abstract][Full Text] [Related]
20. Influence of tensides on the release of medical agents from hydrophilic gels, part 2: The influence of selected tensides on hydrocortisone release from xerogels.
Szcześniak M; Kubis AA
Pharmazie; 2004 Mar; 59(3):198-9. PubMed ID: 15074592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
